Monitoring treatment toxicities in patients with renal cell carcinoma
Drs Dan George and Tian Zhang from the Duke Prostate [...]
Drs Dan George and Tian Zhang from the Duke Prostate [...]
A recent literature review and network meta-analysis of phase 2/3 [...]
The past decade or so has seen the development of [...]
In 2015, the standard treatment for most patients with advanced [...]
Over the past couple of years there have been several [...]
In this interview with OncLive, professor Sumanta Kumar Pal from [...]
A recent study published in the journal Translational Oncology suggests [...]
In this video interview, Dr Eric Jonasch from MD Anderson [...]
In this retrospective international study, the effectiveness of targeted therapy [...]
Approval of axitinib plus pembrolizumab and axitinib plus avelumab in [...]